2019
DOI: 10.1111/bjd.17609
|View full text |Cite
|
Sign up to set email alerts
|

Quantitative survey into value clarification of discussed treatment options among patients treated for basal cell carcinoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 6 publications
(7 reference statements)
0
2
0
Order By: Relevance
“…5,6 In a recent prospective Greek cohort study of 977 patients with melanoma, the risk of developing a second primary melanoma within the first 5 years was 8Á0%. 7 We cannot conclude from our observational study that anti-PD-1 mAb treatment could decrease this risk.…”
mentioning
confidence: 78%
See 1 more Smart Citation
“…5,6 In a recent prospective Greek cohort study of 977 patients with melanoma, the risk of developing a second primary melanoma within the first 5 years was 8Á0%. 7 We cannot conclude from our observational study that anti-PD-1 mAb treatment could decrease this risk.…”
mentioning
confidence: 78%
“…It was assumed that these patients will not benefit from a PDA. To evaluate which values Dutch patients deemed important, our research group conducted a survey 7 . The part on ‘value and preference elicitation’ was based on the literature search (international) and the survey (national).…”
Section: Topic Patients Adaptions Professionals Adaptationsmentioning
confidence: 99%